Introduction
Managing glaucoma and ocular hypertension often requires long-term treatment to help reduce pressure inside the eye and protect vision. Elevated intraocular pressure can damage the optic nerve over time, potentially leading to permanent vision loss if left untreated. For many patients, consistent pressure control is an important part of preserving eye health and reducing the risk of disease progression.
Durysta is an innovative prescription treatment that offers a different approach to intraocular pressure management. Unlike traditional glaucoma medications that require daily eye drop administration, Durysta is a biodegradable implant that is placed directly inside the eye by an ophthalmologist or other qualified eye care professional. The implant gradually releases medication over time, providing sustained intraocular pressure reduction without the need for daily topical dosing.
Because Durysta is a specialty ophthalmology treatment that includes both the implant and a medical procedure, treatment costs can be high. Many patients researching the Durysta patient assistance program are seeking ways to reduce out-of-pocket costs while maintaining access to effective glaucoma treatment.
Prescription Hope offers access to affordable brand-name medications for qualified patients.
What Is the Durysta Patient Assistance Program?
Understanding Durysta Prescription Assistance
Patients who need help paying for Durysta understand the burden of expensive prescription costs and the burden of finding ways to save.
Pharmaceutical manufacturers understand their brand-name medications may be too expensive for the average American. Therefore, they often launch patient assistance programs to help those who are financially struggling.
However, some programs are difficult to apply for, often leaving patients confused and frustrated.
Prescription Hope can help.
How Expert Advocates Help Make Durysta More Affordable
Personalized Medication Assistance
Prescription Hope offers Durysta application help for Durysta Patient Assistance Program applicants. Our medication advocate support includes completing forms, collecting documents and signatures, and coordinating with healthcare providers as well as the manufacturers.
Ongoing Patient Support
Our team doesn’t just help with applications. Prescription Hope patient advocates offer patient-centered support for long-term medication assistance. This means we handle the necessary administrative tasks that come with patient assistance programs.
From refill schedules to document updates and yearly renewals, we manage it so you don’t have to.
Navigating Specialty Treatment Costs
Prescription Hope’s glaucoma treatment affordability access is a simple $70.00 per month, per medication. With all of our specialty drug assistance, our service rate remains the same. No hassles, hidden fees, or medication costs.
Durysta Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Durysta Patient Assistance Eligibility
General Eligibility Requirements
Wondering who qualifies for Durysta assistance?
General eligibility requirements include:
Insurance: Each program maintains its own requirements regarding insurance coverage status.
Income: Every program differs with income threshold criteria.
Prescription: All programs require a valid prescription for the brand-name medication being applied for.
U.S. Residency: All patients must be legal U.S. residents.
Simple Enrollment With Expert Support
Getting Started With Enrollment
If you need patient assistance registration and are looking for guidance through the Durysta application process, then be sure to enroll with Prescription Hope. Our enrollment journey only takes 6 steps, which include:
- Submit Information: Our enrollment form takes just a few minutes to complete.
- Advocate Contact: Once we receive your enrollment form, a patient advocate will reach out within 1-2 business days.
- Document Collection: After we’ve prequalified you, we’ll collect all necessary documentation
- Provider Coordination: Our team coordinates with your healthcare provider to secure all necessary signatures.
- Program Submission: We put everything together and submit your application. Our team continues to coordinate with the manufacturer throughout the processing stage.
- Medication Delivery: After approval, patients typically receive their medication within 2 weeks. All medication ships directly from the manufacturer to the patient’s door or doctor’s office.
Understanding Durysta
How Durysta Works
Durysta contains bimatoprost, a prostaglandin analog medication that helps lower pressure inside the eye. Elevated intraocular pressure occurs when fluid inside the eye, known as aqueous humor, does not drain efficiently. Over time, increased pressure can damage the optic nerve and contribute to vision loss.
Bimatoprost works by increasing the outflow of aqueous humor from the eye. As fluid drains more effectively, intraocular pressure decreases. Lowering intraocular pressure is an important goal in the treatment of open-angle glaucoma and ocular hypertension.
Unlike traditional glaucoma eye drops, Durysta delivers bimatoprost through a biodegradable implant placed directly into the anterior chamber of the eye. The implant gradually releases medication over time, providing sustained drug delivery without requiring daily topical administration.
What Conditions Does Durysta Treat?
Durysta is FDA-approved for the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension.
Open-angle glaucoma is the most common form of glaucoma and develops when drainage pathways within the eye become less effective over time. Ocular hypertension refers to elevated pressure inside the eye that may increase the risk of developing glaucoma and optic nerve damage.
Healthcare providers may recommend Durysta for patients who require long-term intraocular pressure reduction and who may benefit from a sustained-release treatment option. The implant offers an alternative method of delivering bimatoprost without the need for daily eye drop use.
Benefits of Treatment
Durysta provides sustained delivery of bimatoprost directly inside the eye through a biodegradable implant. This approach offers a unique alternative to traditional topical glaucoma therapies.
Potential benefits include lowering elevated intraocular pressure, providing continuous medication delivery over time, reducing reliance on daily eye drops, and offering a long-acting treatment option for appropriate patients. Because the implant slowly releases medication after placement, patients do not need to administer the medication themselves each day.
Clinical studies demonstrated significant reductions in intraocular pressure following implantation. By helping control intraocular pressure, Durysta may play an important role in glaucoma management and the protection of long-term vision.
Important Safety Information and Side Effects
Durysta does not carry an FDA Boxed Warning. However, important safety considerations exist because the medication is delivered directly into the eye through an intracameral implant.
The most commonly reported side effects include eye redness, eye irritation, foreign body sensation, eye pain, increased tearing, sensitivity to light, dry eye, blurred vision, corneal endothelial cell loss, and corneal edema. Most side effects are localized to the treated eye.
Durysta has been associated with corneal endothelial cell loss and corneal edema. Because of this risk, current FDA-approved prescribing information limits administration to a single implant per eye without retreatment. Patients require ongoing ophthalmic monitoring following implantation.
The medication is contraindicated in patients with corneal endothelial cell dystrophy, including Fuchs’ dystrophy, prior corneal transplantation, prior endothelial cell transplantation procedures such as DSAEK, absent or ruptured posterior lens capsules, active ocular or periocular infections, or known hypersensitivity to bimatoprost or implant components.
Additional warnings include corneal adverse reactions, intraocular inflammation, macular edema, pigmentation changes involving the iris or eyelids, implant migration, and procedure-related complications. Patients with uveitis, iritis, or other inflammatory eye conditions may face increased risks.
As with other intraocular procedures, implantation may be associated with risks such as infection, endophthalmitis, bleeding, eye injury, and increased inflammation. Patients should contact their healthcare provider immediately if they experience eye pain, worsening redness, vision changes, or other concerning symptoms after implantation.
Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss potential treatment risks and benefits with their healthcare provider before receiving Durysta.
Regular follow-up examinations typically include intraocular pressure measurements, corneal endothelial cell evaluation, visual assessments, and monitoring for implant-related complications.
Access to Multiple Medications
Support Beyond Durysta
When patients require ophthalmology medication assistance, they often also need specialty medication access for their other brand-name medications.
Prescription Hope helps patients every day access their needed brand-name medications. No matter how many meds a patient qualifies for on Prescription Hope’s list, we can help.
And our service fee stays the same: simple $70.00 per month, per medication.
Why Choose Prescription Hope for Durysta Assistance
Patient-Focused Medication Support
Prescription Hope has offered medication access services for two decades and has helped hundreds of thousands of patients.
Simplified Access to Specialty Therapies
Our fee remains a simple $70.00 per month, per medication. No hassles, hidden fees, or add-ons.
Ongoing Prescription Assistance
Our team of patient advocates offers long-term medication support for all brand-name medications on our list of hundreds of meds.
That means we continue to maintain your account long after approval, securing document updates, managing refill scheduling, and taking care of yearly renewals.
Network Access
Our network extends across the nation and includes hundreds of pharmaceutical manufacturers.
If you’re looking for access to the Durysta Patient Assistance Program, then be sure to enroll with Prescription Hope today to find out how we can help you save!
